CN Stock MarketDetailed Quotes

China Resources Jiangzhong Pharmaceutical (600750)

Watchlist
  • 23.00
  • -0.43-1.84%
Market Closed May 15 15:00 CST
14.62BMarket Cap16.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China Resources Jiangzhong Pharmaceutical (600750) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-12.49%1.04B
-4.87%4.22B
-6.28%2.93B
-5.79%2.14B
-7.03%1.18B
-2.59%4.44B
-3.31%3.13B
-3.78%2.27B
-5.29%1.27B
17.19%4.55B
Operating revenue
-12.49%1.04B
-4.87%4.22B
-6.28%2.93B
-5.79%2.14B
-7.03%1.18B
-2.59%4.44B
-3.31%3.13B
-3.78%2.27B
-5.29%1.27B
17.19%4.55B
Other operating revenue
----
-59.24%12.84M
----
-86.44%2.39M
----
20.15%31.51M
----
-19.09%17.62M
----
-33.75%26.23M
Total operating cost
-18.57%697.8M
-9.49%3.13B
-10.90%2.1B
-10.58%1.51B
-8.90%856.91M
-5.01%3.46B
-7.53%2.36B
-8.49%1.69B
-11.36%940.63M
12.81%3.64B
Operating cost
-12.25%330.26M
-9.69%1.46B
-7.64%995.73M
-4.56%715.15M
-10.44%376.37M
-1.22%1.62B
-0.40%1.08B
-3.93%749.3M
-4.70%420.25M
18.32%1.64B
Operating tax surcharges
2.07%17.91M
2.34%65.8M
-3.41%44.43M
-1.28%32.43M
-2.22%17.55M
1.24%64.29M
-0.67%46M
3.15%32.85M
2.94%17.95M
6.29%63.51M
Operating expense
-27.65%289.59M
-12.94%1.3B
-17.21%883.78M
-19.25%636.8M
-11.71%400.26M
-8.89%1.49B
-14.48%1.07B
-14.33%788.57M
-15.74%453.36M
8.83%1.64B
Administration expense
-12.73%46.64M
-1.89%224.66M
-4.45%135.8M
8.35%97.16M
31.26%53.45M
3.60%229M
-1.75%142.12M
-3.42%89.68M
-19.29%40.72M
7.40%221.03M
Financial expense
13.72%-15.24M
2.97%-73.08M
6.11%-56.71M
3.57%-39.9M
18.11%-17.66M
-23.62%-75.32M
-39.05%-60.4M
-55.62%-41.38M
-73.50%-21.57M
-120.83%-60.93M
-Interest expense (Financial expense)
22.40%284.7K
6.26%1.81M
158.68%716.27K
109.20%483.74K
1,284.33%232.61K
-75.56%1.71M
-92.84%276.9K
-93.24%231.23K
-98.96%16.8K
59.38%6.98M
-Interest Income (Financial expense)
12.67%-15.74M
2.26%-75.73M
4.89%-58.04M
2.61%-40.74M
16.93%-18.02M
-12.64%-77.48M
-27.09%-61.02M
-38.48%-41.84M
-53.30%-21.7M
-110.81%-68.79M
Research and development
6.27%28.64M
17.14%152.79M
15.97%97.14M
-1.79%67.43M
-9.95%26.95M
-7.77%130.43M
18.24%83.77M
50.08%68.66M
12.32%29.92M
41.46%141.42M
Credit Impairment Loss
-1,150.57%-4.66M
-77.47%3.26M
-91.49%1.93M
-95.68%1.02M
-103.39%-372.88K
5,470.58%14.47M
213.58%22.73M
353.44%23.51M
632.19%11.01M
101.85%259.68K
Asset Impairment Loss
1,778.48%13.98M
120.82%3.35M
293.90%18.26M
206.74%9.67M
91.39%-832.94K
-65.34%-16.07M
-190,316.68%-9.42M
-183,122.77%-9.06M
---9.68M
-8,541.20%-9.72M
Other net revenue
-31.38%21.97M
107.40%112.31M
70.00%85.41M
75.58%68.82M
429.90%32.02M
1,539.03%54.15M
14.82%50.24M
-8.92%39.19M
-66.69%6.04M
-96.45%3.3M
Fair value change income
458.23%268.38K
159.88%5.17M
30.49%1.1M
-19.34%681K
-92.25%48.08K
76.75%-8.63M
-85.20%844.29K
-95.09%844.28K
-91.35%620.29K
-164.99%-37.11M
Invest income
-296.67%-217.43K
-61.75%-4.58M
-35.42%-3.53M
18.59%-1.17M
170.45%110.56K
3.70%-2.83M
-373.71%-2.61M
-807.10%-1.44M
55.27%-156.92K
-167.23%-2.94M
-Including: Investment income associates
-104.10%-22.12K
30.86%-675.38K
62.94%-504.09K
255.90%739.1K
443.37%538.82K
66.75%-976.9K
-242.61%-1.36M
-198.94%-474.1K
55.27%-156.92K
-257.74%-2.94M
Asset deal income
-69.35%57.89
-66.55%614.86K
301.81%591.59K
-98.58%992.41
-99.56%188.9
50.80%1.84M
-5,563.92%-293.14K
1,327.24%69.9K
7,235.80%43.38K
1,008.60%1.22M
Other revenue
-61.89%12.6M
59.84%104.5M
71.96%67.05M
131.95%58.62M
686.60%33.07M
26.72%65.38M
30.67%38.99M
21.57%25.27M
-57.19%4.2M
12.32%51.59M
Operating profit
0.31%360.34M
16.59%1.2B
11.62%918.41M
12.29%700.87M
5.93%359.21M
12.65%1.03B
12.48%822.78M
11.30%624.14M
12.32%339.1M
21.97%912.81M
Add:Non operating Income
-16.72%375.48K
287.48%31.82M
257.16%22.14M
266.04%17.8M
-62.58%450.85K
-15.22%8.21M
-21.60%6.2M
-10.20%4.86M
-76.13%1.2M
32.37%9.69M
Less:Non operating expense
-66.83%221.33K
65.49%18.03M
215.25%16.85M
1,210.09%15.43M
86.78%667.17K
70.81%10.9M
293.79%5.35M
30.52%1.18M
-28.74%357.2K
161.02%6.38M
Total profit
0.42%360.5M
18.24%1.21B
12.15%923.7M
12.01%703.24M
5.60%358.99M
11.95%1.03B
11.59%823.63M
11.06%627.82M
10.93%339.95M
21.62%916.12M
Less:Income tax cost
-7.18%48.54M
36.38%225.17M
47.06%181.01M
51.56%143.82M
2.52%52.3M
27.88%165.11M
11.34%123.08M
7.39%94.89M
9.19%51.01M
20.79%129.11M
Net profit
1.71%311.95M
14.76%987.55M
6.02%742.69M
4.97%559.42M
6.15%306.7M
9.34%860.51M
11.64%700.55M
11.74%532.93M
11.24%288.94M
21.75%787.01M
Net profit from continuing operation
1.71%311.95M
14.76%987.55M
6.02%742.69M
4.97%559.42M
6.15%306.7M
9.34%860.51M
11.64%700.55M
11.74%532.93M
11.24%288.94M
21.75%787.01M
Less:Minority Profit
9.76%23.91M
11.82%80.87M
11.81%59.24M
-5.50%37.08M
9.36%21.78M
5.82%72.31M
50.54%52.98M
44.61%39.24M
15.90%19.92M
41.92%68.34M
Net profit of parent company owners
1.10%288.04M
15.03%906.69M
5.54%683.45M
5.80%522.34M
5.91%284.91M
9.67%788.19M
9.33%647.57M
9.76%493.69M
10.91%269.02M
20.13%718.67M
Earning per share
Basic earning per share
2.22%0.46
14.40%1.43
4.85%1.08
3.80%0.82
4.65%0.45
9.65%1.25
9.57%1.03
9.72%0.79
10.26%0.43
20.00%1.14
Diluted earning per share
2.22%0.46
14.40%1.43
4.85%1.08
3.80%0.82
4.65%0.45
9.65%1.25
9.57%1.03
9.72%0.79
10.26%0.43
20.00%1.14
Other composite income
Total composite income
1.71%311.95M
14.76%987.55M
6.02%742.69M
4.97%559.42M
6.15%306.7M
9.34%860.51M
11.64%700.55M
11.74%532.93M
11.24%288.94M
21.75%787.01M
Total composite income of parent company owners
1.10%288.04M
15.03%906.69M
5.54%683.45M
5.80%522.34M
5.91%284.91M
9.67%788.19M
9.33%647.57M
9.76%493.69M
10.91%269.02M
20.13%718.67M
Total composite income of minority owners
9.76%23.91M
11.82%80.87M
11.81%59.24M
-5.50%37.08M
9.36%21.78M
5.82%72.31M
50.54%52.98M
44.61%39.24M
15.90%19.92M
41.92%68.34M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -12.49%1.04B-4.87%4.22B-6.28%2.93B-5.79%2.14B-7.03%1.18B-2.59%4.44B-3.31%3.13B-3.78%2.27B-5.29%1.27B17.19%4.55B
Operating revenue -12.49%1.04B-4.87%4.22B-6.28%2.93B-5.79%2.14B-7.03%1.18B-2.59%4.44B-3.31%3.13B-3.78%2.27B-5.29%1.27B17.19%4.55B
Other operating revenue -----59.24%12.84M-----86.44%2.39M----20.15%31.51M-----19.09%17.62M-----33.75%26.23M
Total operating cost -18.57%697.8M-9.49%3.13B-10.90%2.1B-10.58%1.51B-8.90%856.91M-5.01%3.46B-7.53%2.36B-8.49%1.69B-11.36%940.63M12.81%3.64B
Operating cost -12.25%330.26M-9.69%1.46B-7.64%995.73M-4.56%715.15M-10.44%376.37M-1.22%1.62B-0.40%1.08B-3.93%749.3M-4.70%420.25M18.32%1.64B
Operating tax surcharges 2.07%17.91M2.34%65.8M-3.41%44.43M-1.28%32.43M-2.22%17.55M1.24%64.29M-0.67%46M3.15%32.85M2.94%17.95M6.29%63.51M
Operating expense -27.65%289.59M-12.94%1.3B-17.21%883.78M-19.25%636.8M-11.71%400.26M-8.89%1.49B-14.48%1.07B-14.33%788.57M-15.74%453.36M8.83%1.64B
Administration expense -12.73%46.64M-1.89%224.66M-4.45%135.8M8.35%97.16M31.26%53.45M3.60%229M-1.75%142.12M-3.42%89.68M-19.29%40.72M7.40%221.03M
Financial expense 13.72%-15.24M2.97%-73.08M6.11%-56.71M3.57%-39.9M18.11%-17.66M-23.62%-75.32M-39.05%-60.4M-55.62%-41.38M-73.50%-21.57M-120.83%-60.93M
-Interest expense (Financial expense) 22.40%284.7K6.26%1.81M158.68%716.27K109.20%483.74K1,284.33%232.61K-75.56%1.71M-92.84%276.9K-93.24%231.23K-98.96%16.8K59.38%6.98M
-Interest Income (Financial expense) 12.67%-15.74M2.26%-75.73M4.89%-58.04M2.61%-40.74M16.93%-18.02M-12.64%-77.48M-27.09%-61.02M-38.48%-41.84M-53.30%-21.7M-110.81%-68.79M
Research and development 6.27%28.64M17.14%152.79M15.97%97.14M-1.79%67.43M-9.95%26.95M-7.77%130.43M18.24%83.77M50.08%68.66M12.32%29.92M41.46%141.42M
Credit Impairment Loss -1,150.57%-4.66M-77.47%3.26M-91.49%1.93M-95.68%1.02M-103.39%-372.88K5,470.58%14.47M213.58%22.73M353.44%23.51M632.19%11.01M101.85%259.68K
Asset Impairment Loss 1,778.48%13.98M120.82%3.35M293.90%18.26M206.74%9.67M91.39%-832.94K-65.34%-16.07M-190,316.68%-9.42M-183,122.77%-9.06M---9.68M-8,541.20%-9.72M
Other net revenue -31.38%21.97M107.40%112.31M70.00%85.41M75.58%68.82M429.90%32.02M1,539.03%54.15M14.82%50.24M-8.92%39.19M-66.69%6.04M-96.45%3.3M
Fair value change income 458.23%268.38K159.88%5.17M30.49%1.1M-19.34%681K-92.25%48.08K76.75%-8.63M-85.20%844.29K-95.09%844.28K-91.35%620.29K-164.99%-37.11M
Invest income -296.67%-217.43K-61.75%-4.58M-35.42%-3.53M18.59%-1.17M170.45%110.56K3.70%-2.83M-373.71%-2.61M-807.10%-1.44M55.27%-156.92K-167.23%-2.94M
-Including: Investment income associates -104.10%-22.12K30.86%-675.38K62.94%-504.09K255.90%739.1K443.37%538.82K66.75%-976.9K-242.61%-1.36M-198.94%-474.1K55.27%-156.92K-257.74%-2.94M
Asset deal income -69.35%57.89-66.55%614.86K301.81%591.59K-98.58%992.41-99.56%188.950.80%1.84M-5,563.92%-293.14K1,327.24%69.9K7,235.80%43.38K1,008.60%1.22M
Other revenue -61.89%12.6M59.84%104.5M71.96%67.05M131.95%58.62M686.60%33.07M26.72%65.38M30.67%38.99M21.57%25.27M-57.19%4.2M12.32%51.59M
Operating profit 0.31%360.34M16.59%1.2B11.62%918.41M12.29%700.87M5.93%359.21M12.65%1.03B12.48%822.78M11.30%624.14M12.32%339.1M21.97%912.81M
Add:Non operating Income -16.72%375.48K287.48%31.82M257.16%22.14M266.04%17.8M-62.58%450.85K-15.22%8.21M-21.60%6.2M-10.20%4.86M-76.13%1.2M32.37%9.69M
Less:Non operating expense -66.83%221.33K65.49%18.03M215.25%16.85M1,210.09%15.43M86.78%667.17K70.81%10.9M293.79%5.35M30.52%1.18M-28.74%357.2K161.02%6.38M
Total profit 0.42%360.5M18.24%1.21B12.15%923.7M12.01%703.24M5.60%358.99M11.95%1.03B11.59%823.63M11.06%627.82M10.93%339.95M21.62%916.12M
Less:Income tax cost -7.18%48.54M36.38%225.17M47.06%181.01M51.56%143.82M2.52%52.3M27.88%165.11M11.34%123.08M7.39%94.89M9.19%51.01M20.79%129.11M
Net profit 1.71%311.95M14.76%987.55M6.02%742.69M4.97%559.42M6.15%306.7M9.34%860.51M11.64%700.55M11.74%532.93M11.24%288.94M21.75%787.01M
Net profit from continuing operation 1.71%311.95M14.76%987.55M6.02%742.69M4.97%559.42M6.15%306.7M9.34%860.51M11.64%700.55M11.74%532.93M11.24%288.94M21.75%787.01M
Less:Minority Profit 9.76%23.91M11.82%80.87M11.81%59.24M-5.50%37.08M9.36%21.78M5.82%72.31M50.54%52.98M44.61%39.24M15.90%19.92M41.92%68.34M
Net profit of parent company owners 1.10%288.04M15.03%906.69M5.54%683.45M5.80%522.34M5.91%284.91M9.67%788.19M9.33%647.57M9.76%493.69M10.91%269.02M20.13%718.67M
Earning per share
Basic earning per share 2.22%0.4614.40%1.434.85%1.083.80%0.824.65%0.459.65%1.259.57%1.039.72%0.7910.26%0.4320.00%1.14
Diluted earning per share 2.22%0.4614.40%1.434.85%1.083.80%0.824.65%0.459.65%1.259.57%1.039.72%0.7910.26%0.4320.00%1.14
Other composite income
Total composite income 1.71%311.95M14.76%987.55M6.02%742.69M4.97%559.42M6.15%306.7M9.34%860.51M11.64%700.55M11.74%532.93M11.24%288.94M21.75%787.01M
Total composite income of parent company owners 1.10%288.04M15.03%906.69M5.54%683.45M5.80%522.34M5.91%284.91M9.67%788.19M9.33%647.57M9.76%493.69M10.91%269.02M20.13%718.67M
Total composite income of minority owners 9.76%23.91M11.82%80.87M11.81%59.24M-5.50%37.08M9.36%21.78M5.82%72.31M50.54%52.98M44.61%39.24M15.90%19.92M41.92%68.34M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -